Stocks and Investing Stocks and Investing
Mon, October 11, 2021
Sun, October 10, 2021
Fri, October 8, 2021

Salveen Richter Downgraded (ALLO) to Hold and Decreased Target to $20 on, Oct 8th, 2021


Published on 2024-10-27 18:06:20 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Downgraded "Allogene Therapeutics, Inc." (ALLO) to Hold and Decreased Target from $71 to $20 on, Oct 8th, 2021.

Salveen has made no other calls on ALLO in the last 4 months.



There is 1 other peer that has a rating on ALLO. Out of the 1 peers that are also analyzing ALLO, 0 agree with Salveen's Rating of Hold.



This is the rating of the analyst that currently disagrees with Salveen


  • Dane Leone of "Raymond James" Upgraded from Hold to Buy and Held Target at $36 on, Friday, September 24th, 2021
Contributing Sources